⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3883020 | 0.72 | — | — | |
| SCHEMBL3885051 | 0.72 | — | — | |
| SCHEMBL3519958 | 0.71 | — | — | |
| SCHEMBL28980646 | 0.70 | — | — | |
| SCHEMBL3338127 | 0.69 | — | — | |
| SCHEMBL1827788 | 0.67 | — | — | |
| SCHEMBL4553323 | 0.67 | — | — | |
| SCHEMBL11083971 | 0.66 | — | — | |
| SCHEMBL13740193 | 0.65 | — | — | |
| SCHEMBL29441814 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101687867-B | Imidazoquinolines with immuno-modulating properties | ASTRAZENECA AB | 2013-10-02 | — | — | CN | disclosed |
| CN-101687867-A | imidazoquinolines with immuno-modulating properties | ASTRAZENECA AB | 2010-03-31 | — | — | CN | disclosed |
| US-20040072798-A1 | Compositions comprising cyclodextrins and no-releasing drugs | NICOX S.A. (FR) | 2004-04-15 | — | — | US | disclosed |
| EP-1347782-A1 | COMPOSITIONS COMPRISING CYCLODEXTRINS AND NO-RELEASING DRUGS | Nicox S.A. (FR) | 2003-10-01 | — | — | EP | disclosed |
| WO-2002053188-A1 | COMPOSITIONS COMPRISING CYCLODEXTRINS AND NO-RELEASING DRUGS | NICOX S.A. (FR) | 2002-07-11 | — | — | WO | disclosed |
| EP-1219306-A1 | Compositions comprising cyclodextrins and NO- releasing drugs | NICOX S.A. (FR) | 2002-07-03 | — | — | EP | disclosed |